Development of Staccato Prochlorperazine for the treatment of migraine headache.
- Subjects who have migraine headache with or without aura (diagnosis according to
International Headache Society guidelines) for at least 6 months, who have been pain
free for at least 48 hours since the end of their last migraine attack, who have a
pain rating of Moderate or Severe prior to dosing.
- Subjects who have taken any other migraine or pain medication within 48 hours of
randomization, with a history of allergy or intolerance to phenothiazines and related
drugs, or are considered by the investigator, for any reason, to be an unsuitable
candidate for receiving prochlorperazine, or unable to use the inhalation device,
must be excluded.